Publications

  1. Croome KP, Lee DD, Nguyen JH, Keaveny AP, Taner CB. Waitlist Outcomes for Patients Relisted Following Failed Donation After Cardiac Death Liver Transplant: Implications for Awarding Model for End-Stage Liver Disease Exception Scores. Am J Transplant. 2017 Sep; 17 (9):2420-2427 Epub 2017 July 07
    View PubMed
  2. Croome KP, Lee DD, Keaveny AP, Taner CB. Noneligible Donors as a Strategy to Decrease the Organ Shortage. Am J Transplant. 2017 Jun; 17: (6)1649-1655.
    View PubMed
  3. Palmer WC, Lee D, Burns J, Croome K, Rosser B, Patel T, Keaveny AP, Pungpapong S, Satyanarayana R, Yataco M, Nakhleh R, Musto KR, Canabal AM, Turnage AK, Hodge DO, Nguyen JH, Harnois DM. Liver Transplantation for Hepatocellular Carcinoma: Impact of Wait Time at a Single Center. Ann Hepatol. 2017 May - Jun; 16 (3):402-411
    View PubMed
  4. Croome KP, Lee DD, Perry DK, Burns JM, Nguyen JH, Keaveny AP, Taner CB. Comparison of longterm outcomes and quality of life in recipients of donation after cardiac death liver grafts with a propensity-matched cohort. Liver Transpl. 2017 Mar; 23 (3):342-351
    View PubMed
  5. Croome KP, Lee DD, Keaveny AP, Taner CB. Improving National Results in Liver Transplantation Using Grafts From Donation After Cardiac Death Donors. Transplantation. 2016 Dec; 100: (12)2640-2647.
    View PubMed
  6. Croome KP, Lee DD, Burns JM, Perry DK, Nguyen JH, Keaveny AP, Wadei HM, Taner CB. Simultaneous liver and kidney transplantation in elderly patients Outcomes and validation of a clinical risk score for patient selection..2016;().
  7. Croome KP, Lee DD, Keaveny AP, Burcin Taner C. IMPROVING NATIONAL RESULTS IN LIVER TRANSPLANTATION USING GRAFTS FROM DONATION AFTER CARDIAC DEATH DONORS. Transplantation. 2016 Sep 21;
    View PubMed
  8. Yataco M, Cowell A, David W, Keaveny AP, Taner CB, Patel T. Predictors and impacts of hospital readmissions following liver transplantation. Ann Hepatol. 2016 May-Jun; 15: (3)356-62.
    View PubMed
  9. Singh S, Venkatesh SK, Keaveny A, Adam S, Miller FH, Asbach P, Godfrey EM, Silva AC, Wang Z, Murad MH, Asrani SK, Lomas DJ, Ehman RL. Diagnostic accuracy of magnetic resonance elastography in liver transplant recipients: A pooled analysis. Ann Hepatol. 2016 May-Jun; 15 (3):363-76
    View PubMed
  10. Wadei HM, Lee DD, Croome KP, Mai ML, Golan E, Brotman R, Keaveny AP, Taner CB. Early Allograft Dysfunction After Liver Transplantation Is Associated With Short- and Long-Term Kidney Function Impairment. Am J Transplant. 2016 Mar; 16: (3)850-9.
    View PubMed
  11. Lee DD, Croome KP, Shalev JA, Musto KR, Sharma M, Keaveny AP, Taner CB. Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements. Ann Hepatol. 2016 Jan-Feb; 15: (1)53-60.
    View PubMed
  12. Giesbrandt KJ, Bulatao IG, Keaveny AP, Nguyen JH, Paz-Fumagalli R, Taner CB. Radiologic Characterization of Ischemic Cholangiopathy in Donation-After-Cardiac-Death Liver Transplants and Correlation With Clinical Outcomes. AJR Am J Roentgenol. 2015 Nov; 205: (5)976-84.
    View PubMed
  13. Croome KP, Lee DD, Burns JM, Perry DK, Nguyen JH, Keaveny AP, Wadei HM, Taner CB. Simultaneous liver and kidney transplantation in elderly patients: Outcomes and validation of a clinical risk score for patient selection Annals of Hepatology. 2016; 15: (6)870-80.
  14. Aqel BA, Pungpapong S, Leise M, Werner KT, Chervenak AE, Watt KD, Murphy JL, Ryland K, Keaveny AP, McLemore R, Vargas HE. Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis. Hepatology. 2015 Oct; 62 (4):1004-12 Epub 2015 Aug 07
    View PubMed
  15. Ngamruengphong S, Horsley-Silva JL, Hines SL, Pungpapong S, Patel TC, Keaveny AP. Educational Intervention in Primary Care Residents' Knowledge and Performance of Hepatitis B Vaccination in Patients with Diabetes Mellitus. South Med J. 2015 Sep; 108: (9)510-5.
    View PubMed
  16. Pungpapong S, Aqel B, Leise M, Werner KT, Murphy JL, Henry TM, Ryland K, Chervenak AE, Watt KD, Vargas HE, Keaveny AP. Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant. Hepatology. 2015 Jun; 61(6):1880-6. Epub 2015 Apr 27.
    View PubMed
  17. Ngamruengphong S, Seeger KM, McCrone LM, Moris M, Garrison SJ, Pungpapong S, Keaveny AP, Raimondo M. Prevalence and outcomes of cystic lesion of the pancreas in immunosuppressed patients with solid organ transplantation. Dig Liver Dis. 2015 May; 47: (5)417-22.
    View PubMed
  18. Chaney A, Heckman M, Diehl N, Meek S, Keaveny A. Effectiveness and Outcomes of Current Practice in Treating Vitamin D Deficiency in Patients Listed for Liver Transplantation. Endocr Pract. 2015 Mar 18; 1-26.
    View PubMed
  19. Singh S, Venkatesh SK, Wang Z, Miller FH, Motosugi U, Low RN, Hassanein T, Asbach P, Godfrey EM, Yin M, Chen J, Keaveny AP, Bridges M, Bohte A, Murad MH, Lomas DJ, Talwalkar JA, Ehman RL. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. Clin Gastroenterol Hepatol. 2015 Mar; 13: (3)440-451.e6.
    View PubMed
  20. Croome KP, Lee DD, Burns JM, Perry DK, Keaveny AP, Taner CB. Patterns and Outcomes Associated with Patient Migration for Liver Transplantation in the United States. PLoS One. 2015; 10: (10)e0140295.
    View PubMed
  21. Wadei HM, Heckman MG, Rawal B, Taner CB, Mai ML, Cortese C, Rosser BG, Gonwa TA, Keaveny AP. Renal outcomes of liver transplant recipients who had pretransplant kidney biopsy. Transplantation. 2014 Dec 27; 98(12):1323-30.
    View PubMed
  22. Wallace MB, Crook JE, Coe S, Ussui V, Staggs E, Almansa C, Patel MK, Bouras E, Cangemi J, Keaveny A, Picco M, Riegert-Johnson D. Accuracy of in vivo colorectal polyp discrimination by using dual-focus high-definition narrow-band imaging colonoscopy. Gastrointest Endosc. 2014 Dec; 80(6):1072-87. Epub 2014 Jun 25.
    View PubMed
  23. Bulatao IG, Heckman MG, Rawal B, Aniskevich S, Shine TS, Keaveny AP, Perry DK, Canabal J, Willingham DL, Taner CB. Avoiding stay in the intensive care unit after liver transplantation: a score to assign location of care. Am J Transplant. 2014 Sep; 14(9):2088-96. Epub 2014 Aug 01.
    View PubMed
  24. Sheikh-Ali M, Keaveny AP, Chamseddin A, Aguirre L, Clarke B, Meek S. 25-Hydroxyvitamin D levels and acute cellular rejection in liver transplant patients. Endocr Pract. 2014 Aug; 20: (8)769-74.
    View PubMed
  25. Wadei HM, Bulatao IG, Gonwa TA, Mai ML, Prendergast M, Keaveny AP, Rosser BG, Taner CB. Inferior long-term outcomes of liver-kidney transplantation using donation after cardiac death donors: single-center and organ procurement and transplantation network analyses. Liver Transpl. 2014 Jun; 20(6):728-35.
    View PubMed
  26. Lee DD, Croome KP, Perry DK, Burns JM, Nguyen JH, Keaveny AP, Taner CB. Liver Transplantation at Mayo Clinic Florida. Clin Transpl. 2014; 83-90.
    View PubMed
  27. Crespo S, Bridges M, Nakhleh R, McPhail A, Pungpapong S, Keaveny AP. Non-invasive assessment of liver fibrosis using magnetic resonance elastography in liver transplant recipients with hepatitis C. Clin Transplant. 2013 Sep-Oct; 27: (5)652-8.
    View PubMed
  28. Pungpapong S, Aqel BA, Koning L, Murphy JL, Henry TM, Ryland KL, Yataco ML, Satyanarayana R, Rosser BG, Vargas HE, Charlton MR, Keaveny AP. Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation. Liver Transpl. 2013 Jul; 19: (7)690-700.
    View PubMed
  29. Wadei HM, Zaky ZS, Keaveny AP, Rosser B, Jones M, Mai ML, Bulatao I, Gonwa TA. Proteinuria following sirolimus conversion is associated with deterioration of kidney function in liver transplant recipients. Transplantation. 2012 May 27; 93(10):1006-12.
    View PubMed
  30. Taner CB, Bulatao IG, Willingham DL, Perry DK, Sibulesky L, Pungpapong S, Aranda-Michel J, Keaveny AP, Kramer DJ, Nguyen JH. Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors. Liver Transpl. 2012 Jan; 18(1):100-11.
    View PubMed
  31. Taner CB, Bulatao IG, Keaveny AP, Willingham DL, Pungpapong S, Perry DK, Rosser BG, Harnois DM, Aranda-Michel J, Nguyen JH. Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus. Liver Transpl. 2011 Jun; 17(6):641-9.
    View PubMed
  32. Dickson RC, Pungpapong S, Keaveny AP, Taner CB, Ghabril M, Aranda-Michel J, Satyanarayana R, Bonatti H, Kramer DJ, Nguyen JH. Improving graft survival for patients undergoing liver transplantation. Clin Transplant. 2011 May-Jun; 25(3):E345-55. Epub 2011 Mar 23.
    View PubMed
  33. Taner CB, Balci D, Willingham DL, Keaveny AP, Rosser BG, Canabal JM, Shine TS, Harnois DM, Kramer DJ, Nguyen JH. Long-term outcomes after third liver transplant. Exp Clin Transplant. 2011 Apr; 9(2):98-104.
    View PubMed
  34. Begum R, Harnois D, Satyanarayana R, Krishna M, Halling KC, Kim GP, Nguyen JH, Keaveny AP. Retransplantation for donor-derived neuroendocrine tumor. Liver Transpl. 2011 Jan; 17(1):83-7.
    View PubMed
  35. Hughes CB, Dickson RC, Krishna M, Willingham DL, Satyanarayana R, Harnois DM, Keaveny AP, Rosser B, Aranda-Michel J, Kramer DJ, Hellinger W, Mendez J. HCV recurrence in HIV-infected patients after liver transplant. J Int Assoc Physicians AIDS Care (Chic). 2010 Mar-Apr; 9(2):87-93. Epub 2010 Mar 31.
    View PubMed
  36. Grewal HP, Willingham DL, Nguyen J, Hewitt WR, Taner BC, Cornell D, Rosser BG, Keaveny AP, Aranda-Michel J, Satyanarayana R, Harnois D, Dickson RC, Kramer DJ, Hughes CB. Liver transplantation using controlled donation after cardiac death donors: an analysis of a large single-center experience. Liver Transpl. 2009 Sep; 15(9):1028-35.
    View PubMed
  37. Gill KR, Pelaez-Luna M, Keaveny A, Woodward TA, Wallace MB, Chari ST, Smyrk TC, Takahashi N, Clain JE, Levy MJ, Pearson RK, Petersen BT, Topazian MD, Vege SS, Kendrick M, Farnell MB, Raimondo M. Branch duct intraductal papillary mucinous neoplasm of the pancreas in solid organ transplant recipients. Am J Gastroenterol. 2009 May; 104(5):1256-61. Epub 2009 Apr 07.
    View PubMed
  38. Ghabril M, Dickson RC, Krishna M, Bonatti H, Aranda-Michel J, Keaveny AP, Satyanarayana R, Hewitt W, Hughes CB, Nguyen JH. Liver transplantation using young pediatric donor grafts in adults with hepatitis C infection. Transplantation. 2009 Apr 27; 87(8):1174-9.
    View PubMed
  39. Nguyen JH, Bonatti H, Dickson RC, Hewitt WR, Grewal HP, Willingham DL, Harnois DM, Schmitt TM, Machicao VI, Ghabril MS, Keaveny AP, Aranda-Michel J, Satyanarayana R, Rosser BG, Hinder RA, Steers JL, Hughes CB. Long-term outcomes of donation after cardiac death liver allografts from a single center. Clin Transplant. 2009 Mar-Apr; 23(2):168-73. Epub 2009 Feb 11.
    View PubMed
  40. Ghabril M, Dickson RC, Krishna M, Lloyd R, Aranda-Michel J, Keaveny A, Satyanarayana R, Bonatti H. Persistence of hepatitis C RNA in liver allografts is associated with histologic progression independent of serologic viral clearance. J Transplant. 2009; 2009:297528. Epub 2009 May 05.
    View PubMed
  41. Keaveny AP, Sigal SS. Effect of Hepatorenal syndrome resolution on transplant and transplant-free outcomes. US Gastroenterology and Hepatology Review. 2009; 5:31-36.
  42. Wadei HM, Geiger XJ, Cortese C, Mai ML, Kramer DJ, Rosser BG, Keaveny AP, Willingham DL, Ahsan N, Gonwa TA. Kidney allocation to liver transplant candidates with renal failure of undetermined etiology: role of percutaneous renal biopsy. Am J Transplant. 2008 Dec; 8(12):2618-26.
    View PubMed
  43. Pungpapong S, Nunes DP, Krishna M, Nakhleh R, Chambers K, Ghabril M, Dickson RC, Hughes CB, Steers J, Nguyen JH, Keaveny AP. Serum fibrosis markers can predict rapid fibrosis progression after liver transplantation for hepatitis C. Liver Transpl. 2008 Sep; 14: (9)1294-302.
    View PubMed
  44. Aranda-Michel J, Dickson RC, Bonatti H, Crossfield JR, Keaveny AP, Vasquez AR. Patient selection for liver transplant: 1-year experience with 555 patients at a single center. Mayo Clin Proc. 2008 Feb; 83(2):165-8.
    View PubMed
  45. Ghabril M, Dickson RC, Machicao VI, Aranda-Michel J, Keaveny A, Rosser B, Bonatti H, Krishna M, Yataco M, Satyanarayana R, Harnois D, Hewitt W, Willingham DD, Grewal H, Hughes CB, Nguyen J. Liver retransplantation of patients with hepatitis C infection is associated with acceptable patient and graft survival. Liver Transpl. 2007 Dec; 13(12):1717-27.
    View PubMed
  46. Pungpapong S, Keaveny A, Raimondo M, Dickson R, Woodward T, Harnois D, Wallace M. Accuracy and interobserver agreement of small-caliber vs. conventional esophagogastroduodenoscopy for evaluating esophageal varices. Endoscopy. 2007 Aug; 39(8):673-80. Epub 2007 Jun 22.
    View PubMed
  47. Pungpapong S, Alvarez S, Hellinger WC, Kramer DJ, Willingham DL, Mendez JC, Nguyen JH, Hewitt WR, Aranda-Michel J, Harnois DM, Rosser BG, Hughes CB, Grewal HP, Satyanarayana R, Dickson RC, Steers JL, Keaveny AP. Peritonitis after liver transplantation: Incidence, risk factors, microbiology profiles, and outcome. Liver Transpl. 2006 Aug; 12(8):1244-52.
    View PubMed
  48. Pungpapong S, Steers JL, Wallace MB, Krishna M, Keaveny AP. Hepatobiliary sarcoidosis mimicking Klatskin's cholangiocarcinoma. Gastrointest Endosc. 2006 Jul; 64(1):124-5.
    View PubMed
  49. Pungpapong S, Krishna M, Abraham SC, Keaveny AP, Dickson RC, Nakhleh RE. Clinicopathologic findings and outcomes of liver transplantation using grafts from donors with unrecognized and unusual diseases. Liver Transpl. 2006 Feb; 12(2):310-5.
    View PubMed
  50. Krishna M, Keaveny AP, Genco PV, Rosser BG, Dickson RC, Nguyen JH, Steers JL, Nakhleh RE. Clinicopathological review of 18 cases of liver allografts lost due to bile duct necrosis. Transplant Proc. 2005 Jun; 37(5):2221-3.
    View PubMed
  51. Nakhleh RE, Krishna M, Keaveny AP, Dickson RC, Rosser B, Nguyen JH, Steers JL. Review of 31 cases of morphologic hepatitis in liver transplant patients not related to disease recurrence. Transplant Proc. 2005 Mar; 37(2):1240-2.
    View PubMed
  52. Keaveny AP, Gordon FD, Goldar-Najafi A, Lewis WD, Pomfret EA, Pomposelli JJ, Jenkins RL, Khettry U. Native liver xanthogranulomatous cholangiopathy in primary sclerosing cholangitis: impact on posttransplant outcome. Liver Transpl.. 2004 Jan; 10: (1)115-22.
    View PubMed
  53. Khettry U, Keaveny A, Goldar-Najafi A, Lewis WD, Pomfret EA, Pomposelli JJ, Jenkins RL, Gordon FD. Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathologic study. Hum Pathol. 2003 Nov; 34(11):1127-36.
    View PubMed
  54. O'Brien MJ, Keating NM, Elderiny S, Cerda S, Keaveny AP, Afdhal NH, Nunes DP. An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C. Am J Clin Pathol. 2000 Nov; 114(5):712-8.
    View PubMed
  55. Keaveny AP, Offner GD, Bootle E, Nunes DP. No significant difference in antigenicity or tissue transglutaminase substrate specificity of Irish and US wheat gliadins. Dig Dis Sci. 2000 Apr; 45(4):755-62.
    View PubMed
  56. Keaveny AP, Karasik MS, Farber HW. Successful treatment of chylous ascites secondary to Mycobacterium avium complex in a patient with the acquired immune deficiency syndrome. Am J Gastroenterol. 1999 Jun; 94(6):1689-90.
    View PubMed
  57. Keaveny AP, Karasik MS. Hepatobiliary and pancreatic infections in AIDS: Part II. AIDS Patient Care STDS. 1998 Jun; 12(6):451-6.
    View PubMed
  58. Keaveny AP, Karasik MS. Hepatobiliary and pancreatic infections in AIDS: Part one. AIDS Patient Care STDS. 1998 May; 12(5):347-57.
    View PubMed
  59. Afdhal NH, Keaveny AP, Cohen SB, Nunes DP, Maldonado N, O'Brien M, Stone PJ. Urinary assays for desmosine and hydroxylysylpyridinoline in the detection of cirrhosis. J Hepatol. 1997 Dec; 27(6):993-1002.
    View PubMed
  60. Salomons H, Keaveny AP, Henihan R, Offner G, Sengupta A, Lamorte WW, Afdhal NH. Nitric oxide and gallbladder motility in prairie dogs. Am J Physiol. 1997 Apr; 272(4 Pt 1):G770-8.
    View PubMed
  61. Keaveny AP, Freaney R, McKenna MJ, Masterson J, O'Donoghue DP. Bone remodeling indices and secondary hyperparathyroidism in celiac disease. Am J Gastroenterol. 1996 Jun; 91(6):1226-31.
    View PubMed